Birdwatch Note Rating
2024-05-01 01:45:10 UTC - HELPFUL
Rated by Participant: D5DEA20C74A66C210C139D1BE7D8F8F58D51030DEEEBFCEF6407EE97863A8907
Participant Details
Original Note:
EBC-46 is a compound with potential anti-cancer properties that has been successfully used in veterinary medicine and is currently being studied for use in humans. However, the claim of it killing cancer in 48 hours should be viewed in the context of ongoing research. https://news.stanford.edu/2022/10/03/breakthrough-production-acclaimed-cancer-treating-drug/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268252/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182759/ https://www.europeanpharmaceuticalreview.com/news/175005/novel-cancer-therapeutic-synthesised-by-stanford-researchers/
All Note Details